OÜ INNOMEDICA

ent_019eed358f04cb12321d5a8cd0c7ca91

Compliance scorecard →🔔 Follow entity

Disclosures

Leak Site · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

unverified actor claims

Identity resolution

Canonical name: OÜ INNOMEDICA
Normalized: ou innomedica— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 894500B8MO6TUP5TGX95
SEC EDGAR CIK: None — not an SEC registrant
Domain: innomedica.com

Unverified threat-actor claim — not a regulatory filing

Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.

Disclosure history (1)newest first

GLOBALLeak Siteas victim2025-05-26
InnoMedica is a Swiss-based biopharmaceutical firm focused on the development of tailored treatments for serious conditions such as cancer and neurological disorders. Its primary product, Talidox, is a nanomedical cancer drug that targets only tumor cells. InnoMedica's research is focused towards the technological advancements in medicine to provide more effective treatments.